Targeting BTK in CLL: Expert Guidance on Selecting Single-Agent and Combination Therapy

Learn how global experts plan optimal BTK inhibitor&ndash based therapy for patients with CLL with downloadable slides and an on-demand webcast from the CCO webinar at the 2021 XIX iwCLL Congress.

Share

Program Content

No activities added yet

Activities

BTK inhibitors in CLL
The Current Role of BTK Inhibitors in CLL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 27, 2021

Expires: September 26, 2022

<i>EP</i>: BTK Inhibitors in CLL
ExpressPoints: Targeting BTK in CLL: Expert Guidance on Selecting Single-Agent and Combination Therapy
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 04, 2021

Expires: November 03, 2022

Faculty

cover img faculity

Seema Ali Bhat, MD

Associate Professor
Division of Hematology
Department of Medicine
The Ohio State University
Columbus, Ohio

cover img faculity

Richard R. Furman, MD

Director, CLL Research Center
Division of Hematology/Oncology
Weill Cornell Medical College
New York, New York

cover img faculity

Talha Munir, MBBS, MRCP, FRCPath

Consultant Haematologist
Department of Haematology
St Jamess Hospital
Leeds, United Kingdom

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca